Index of reports
> Disability (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Alphagan P (Brimonidine Ophthalmic) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Alphagan P side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-15
Patient: female, weighing 53.1 kg (116.8 pounds)
Reactions: Confusional State, Glaucoma, Optic Nerve Disorder, Ileostomy, Drug Interaction, Impaired Driving Ability, Malaise, Skin Discolouration, Procedural Pain, Dyspnoea, Vomiting, Visual Field Defect, Condition Aggravated, Toxicity To Various Agents, Amnesia, Tremor, Diarrhoea, Dysuria, Blindness
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Ethambutol Hydrochloride
Dosage: 500 mg;bid
Indication: Mycobacterium Avium Complex Infection
End date: 2008-06-01
Ethambutol Hydrochloride
Dosage: 500 mg;bid
Indication: Eye Infection Bacterial
End date: 2008-06-01
3 Antibiotics (Unspecified) (NO Pref. Name)
Start date: 2012-01-01
Amikacin
Start date: 2012-01-01
End date: 2012-01-01
Alphagan P
Indication: Mycobacterium Avium Complex Infection
Start date: 2000-01-01
Alphagan P
Indication: Eye Infection Bacterial
Start date: 2000-01-01
Morphine
Start date: 2010-10-01
Other drugs received by patient: Keflex; Vantin; Amoxicillin; Ciprofloxacin; Rifampin; Duragesic-100; Phenazopyridine HCL TAB; Biaxin
|